In today’s pharmaceutical landscape, complexity is the new normal, reports Delphine Perridy, Chief Commercial Officer at Envirotainer.
With decentralised clinical trials, personalised medicines and direct-to-patient therapies on the rise, pharma supply chains must move faster, smarter and more precisely than ever before.
As these needs grow, so too does the role of small parcel shipments.